Summarized by Masters of Longevity from Frontiers - Health.
This clinical research article examines how repeated FIB-4 measurements over time relate to future heart-failure risk in adults with type 2 diabetes, offering a longitudinal biomarker perspective readers can evaluate.
Key Takeaways
- Greater within-person FIB-4 variability over an 18-month assessment window was associated with higher subsequent heart failure hazard.
- Persistent high FIB-4 and progression to a high FIB-4 category predicted increased incident heart failure during follow-up.
- NT-proBNP and high-sensitivity troponin were largely unavailable, so incremental predictive value of serial FIB-4 versus established cardiac biomarkers was not evaluated.
